Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1 MONCTON, NB, June 24, 2019 /PRNewswire/ – Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has received approval from Health Canada for
[Read More ...]
Originally posted on Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A via Vic Neufeld Medical Marijuana News
No comments:
Post a Comment